halothane has been researched along with Addison Disease in 1 studies
Addison Disease: An adrenal disease characterized by the progressive destruction of the ADRENAL CORTEX, resulting in insufficient production of ALDOSTERONE and HYDROCORTISONE. Clinical symptoms include ANOREXIA; NAUSEA; WEIGHT LOSS; MUSCLE WEAKNESS; and HYPERPIGMENTATION of the SKIN due to increase in circulating levels of ACTH precursor hormone which stimulates MELANOCYTES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| O'Daniel, LG | 1 |
1 other study available for halothane and Addison Disease
| Article | Year |
|---|---|
The adrenal gland and the use of cortisone in the management of patients with Addison's disease and Cushing's syndrome.
Topics: Addison Disease; Adrenal Glands; Adult; Anesthesia; Cortisone; Cushing Syndrome; Female; Fentanyl; H | 1983 |